Arabic Arabic English English French French German German
dark

Kriya Therapeutics Completes $100 Million Series B Financing to Advance Its Fully Integrated Platform for Designing, Developing and Manufacturing Transformative Gene Therapies

Kriya Therapeutics, Inc. today announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

COVID Vaccine’s 2nd Dose Boosts Body Immunity, MOH Says

Next Post

Avacta’s Diagnostic Division Achieves ISO 13485 Certification

Related Posts
Total
0
Share